Skip to main content
FDA Updates
FDA News - April 2017
Read More
Immunotherapy
Immunotherapy with Nivolumab plus Ipilimumab Improves Outcomes in Metastatic Urothelial Cancer
Walter Alexander
Read More
Original Research
Clostridium Difficile Infection Retreatment Based on Initial Therapy in Patients with Cancer
Anastasia Finn, PharmD, MBA, BCOP, Jesse Young, PharmD, Kathy Edwards, PharmD, BCPS, BCOP, Andy Perez, PharmD, BCOP, Shawn MacVane, PharmD, BCPS
Read More
Supportive Care
EGFR Inhibitor–Associated Papulopustular Rash
Donald C. Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP
Read More
Novel Systemic Therapies for Advanced Non–Small-Cell Lung Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA, Tristan Lindfelt, PharmD, BCPS, BCACP, BCOP, Eric Lozano
Read More
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
ASH Highlights
Triplet Therapy That Includes Elotuzumab Stops Progression of High-Risk Smoldering Multiple Myeloma
Wayne Kuznar
Read More
ASH Highlights
Obinutuzumab Prolongs Survival in Follicular Lymphoma
Phoebe Starr
Read More
ASH Highlights
CAR T-Cell Therapy Succeeds in Aggressive Lymphoma
Phoebe Starr
Read More
R-CHOP Prevails Over Dose-Adjusted EPOCH-R as Standard of Care for Diffuse Large B-Cell Lymphoma
Phoebe Starr
Read More
Page 165 of 196
Results 1641 - 1650 of 1955